Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Nov 7, 2012; 18(41): 5839-5847
Published online Nov 7, 2012. doi: 10.3748/wjg.v18.i41.5839
Published online Nov 7, 2012. doi: 10.3748/wjg.v18.i41.5839
Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease
Matteo Nicola Dario Di Minno, Anna Russolillo, Pasquale Ambrosino, Alessandro Di Minno, Giovanni Tarantino, Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, “Federico II” University, 80131 Naples, Italy
Roberta Lupoli, Department of Endocrinology and Oncology, “Federico II” University, 80131 Naples, Italy
Author contributions: Di Minno MND and Russolillo A contributed equally to this paper; Di Minno MND performed the manuscript design, searching strategy and manuscript preparation; Russolillo A performed the clinical studies and manuscript preparation; Lupoli R provided the molecular mechanisms; Ambrosino P provided the animal models; Di Minno A performed the bibliographic search; Tarantino G made critical revisions and manuscript preparation.
Correspondence to: Matteo Nicola Dario Di Minno, MD, Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, “Federico II” University, Via S. Pansini 5, 80131 Naples, Italy. dario.diminno@hotmail.it
Telephone: +39-81-7464323 Fax: +39-81-7464323
Received: March 30, 2012
Revised: June 8, 2012
Accepted: June 28, 2012
Published online: November 7, 2012
Revised: June 8, 2012
Accepted: June 28, 2012
Published online: November 7, 2012
Core Tip